<?xml version="1.0" encoding="UTF-8"?>
<ref id="R25">
 <label>25</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name name-style="western">
    <surname>Gay</surname>
    <given-names>CL</given-names>
   </name>, 
   <name name-style="western">
    <surname>Bosch</surname>
    <given-names>RJ</given-names>
   </name>, 
   <name name-style="western">
    <surname>Ritz</surname>
    <given-names>J</given-names>
   </name>, 
   <etal>et al</etal>
  </person-group>
  <article-title>Clinical trial of the anti-PD-L1 antibody BMS-936559 in HIV-1 infected participants on suppressive antiretroviral therapy</article-title>. 
  <source>J Infect Dis</source>
  <year>2017</year>;
  <volume>215</volume>:
  <fpage>1725</fpage>â€“
  <lpage>33</lpage>. 
  <pub-id pub-id-type="doi">10.1093/infdis/jix191</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/28431010?>
  <pub-id pub-id-type="pmid">28431010</pub-id>
 </mixed-citation>
</ref>
